Thus, a tumor-targeting drug carrier was constructed via coating PM on Hb-LOX-DOX-encapsulated ZIF8 to regulate the tumor microenvironment and enhance chemotherapy simultaneously by depleting lactate and relieving hypoxia. This evidence concerns the gene LOX and neoplasm.